Aclaris Therapeutics, Inc. (ACRS)
3.21
-0.07
(-2.13%)
USD |
NASDAQ |
Dec 09, 16:00
3.20
-0.01
(-0.31%)
After-Hours: 20:00
Aclaris Therapeutics Shareholders Equity (Quarterly): 120.10M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 631.90M |
| Puma Biotechnology, Inc. | 115.27M |
| Xencor, Inc. | 625.32M |
| Vivos Therapeutics, Inc. | 2.532M |
| CEL-SCI Corp. | 7.025M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 175.53M |
| Total Liabilities (Quarterly) | 55.43M |
| Debt to Equity Ratio | 0.0187 |
| Current Ratio | 3.925 |
| Net Debt Paydown Yield | 0.06% |